Cipla announces closure of USFDA inspection at Patalganga facility
Posted by
www.biotecnika.org
Cipla recently announced the closure of inspection by United States
Food and Drug Administration (USFDA) at the Patalganga manufacturing
facility in Maharashtra. Shares of Cipla were trading 0.40 per cent
lower at Rs 478.35 apiece on the BSE in the morning trade.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/cipla-announces-closure-of-usfda-inspection-at-patalganga-facility/articleshow/73418979.cms
Subscribe to:
Post Comments (Atom)
Post a Comment